DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in Asia” conference has been added to ResearchAndMarkets.com’s offering.
The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries.
This seminar will provide a practical overview of the key areas of pharmaceutical regulatory affairs in Asia, including India, and will cover all important aspects of gaining and maintaining a successful marketing authorisation within the region. The programme will include:
Benefits of Attending
Agenda
Day 1: China, Hong Kong SAR, Introduction to ASEAN, Brunei and the Philippines
Day 2: India, Indonesia, Malaysia, Singapore, Thailand, Vietnam
Day 3: Taiwan, Korea, brief comparison with Japan, ASEAN harmonisation
Regional presentations covering:
The markets
Company and product registration
Application process
Recent regulatory developments
Harmonisation Initiatives
A brief comparison of how Japan fits into the Asian regulatory landscape
For more information about this conference visit https://www.researchandmarkets.com/r/2lmvt2
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Company Marks Over 10,000 Saplings Planted Since 2019; Supports 1,200 New Plantings with School Eco…
KUALA LUMPUR, MALAYSIA- Media OutReach Newswire - 5 December 2025 - ZTE Corporation (0763.HK /…
DÜSSELDORF, GERMANY - Media OutReach Newswire - 5 December 2025 - Conow, a global AI…
HONG KONG SAR - Media OutReach Newswire - 5 December 2025 - Those prioritizing safety…
SINGAPORE - Media OutReach Newswire - 5 December 2025 - For students seeking an international…
SHANGHAI, CHINA - Media OutReach Newswire - 4 December 2025 - On December 2, 2025,…